The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy

Clinical Endocrinology

Volumn 44, Issue 6, 1996, Pages 711-716

  Soule, Steven G ^a,c   Farhi, Jacob ^a   Conway, Gerard S ^a   Jacobs, Howard S ^a   Powell, Michael ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROLACTINOMA; TREATMENT OUTCOME;

EID: 0029943245     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.738559.x     Document Type: Article

References (24)

1. Aubourg, P.R., Derome, P.J., Peillon, F., Jedynak, C.P., Visot, A., Le-Gentil, P., Balagura, S. & Guist, G. (1980) Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumour size as predicting factors. Surgical Neurology, 14, 141-143.
2. Barrow, D.L., Mizuno, J. & Tindall, G.T. (1988) Management of prolactinomas associated with very high serum prolactin levels. Journal of Neurosurgery, 68, 554-558.
3. Bevan, J.S., Adams, C.B.T., Burke, C.W., Morton, K.E., Molyneux, A.J., Moore, R.A. & Esiri, M.M. (1987) Factors in the outcome of transsphenoidal surgery for prolactinoma and non functioning pituitary tumour, including pre-operative bromocriptine therapy. Clinical Endocrinology, 26, 541-556.
4. Bevan, J.S, Webster, J., Burke, C.W & Scanlon, MF. (1992) Dopamine agonists and pituitary tumor shrinkage. Endocrine Reviews, 13, 220-240.
5. Chang, R.J., Keye, W.R., Young, J.R., Wilson, C.B. & Jaffe, R.B. (1977) Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhoea and amenorrhoea. American Journal of Obstetrics and Gynecology, 128, 356-363.
6. Ciric, I., Mikhael, M., Stafford, T., Lawson, L. & Garces, R. (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long term follow up results. Journal of Neurosurgery, 59, 395-401.
7. Esiri, M.M., Bevan, J.S., Burke, C.W. & Adams, C.B.T. (1986) Effect of Bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland. Journal of Clinical Endocrinology and Metabolism, 63, 383-388.
8. Faglia, G., Moriondo, P., Travaglini, P. & Giovanelli, M.A. (1983) Influence of previous Bromocriptine therapy on surgery for microprolactinomas. Lancet, i, 133-134.
9. Fahlbusch, R. & Buchfelder, M. (1985) Present status of neurosurgery in the treatment of prolactinomas. Neurosurgical Review, 8, 195-205.
10. Faria, M.A. & Tindall, G.T. (1982) Transsphenoidal microsurgery for prolactin secreting pituitary adenomas. Journal of Neursurgery, 56, 33-43.
11. Gen, M., Uozumi, T., Shinohara, S., Naito, M., Ito, A., Mori, S. & Kajawara, H. (1984) Necrotic changes in prolactinomas after long term administration of bromocriptine. Journal of Clinical Endocrinology and Metabolism, 59, 463-470.
12. Klijn, J.G.M., Lamberts, S.W.J., De Jong, F.H., Docter, R., Van Dongen, K.J. & Birkenhager, J.C. (1980) The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour. Clinical Endocrinology, 12, 341-355.
13. Landolt, A.M. & Osterwalder, V. (1984) Perivascular fibrosis in prolactinomas: is it increased by bromocriptine? Journal of Clinical Endocrinology and Metabolism, 58, 1179-1183.
14. Landolt, A.M., Keller, P.J., Froesch, E.R. & Mueller, J. (1982) Bromocriptine: does it jeopardise the result of later surgery for prolactinomas? Lancet, i, 657-658.
15. Molitch, M.E (1995) Prolactinomas, In The Pituitary (ed. S. Melmed), Blackwell Science, Boston.
16. Molitch, M.E. (1992) Pathological hyperprolactinaemia. Endocrinology and Metabolism Clinics of North America, 21, 877-901.
17. Parl, F., Cruz, V.E., Cobb, C.A., Bradley, C.A. & Aleshire, S.L. (1986) Late recurrence of surgically removed prolactinomas. Cancer, 57, 2422-2426.
18. Randall, R.V., Laws, E.R., Abboud, C.F., Ebersold, M.J., Kao, P.C. & Scheithauer, B.W. (1983) Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas-results in 100 patients. Mayo Clinic Proceedings, 58, 108-121.
19. Rodman, E.F., Molitch, M.E., Post, K.D., Biller, B.J. & Reichlin, S. (1984) Long term follow up of transsphenoidal selective adenomectomy for prolactoma. Journal of the American Medical Association, 7, 921-924.
20. Scanlon, M.F., Peters, J.R., Thomas, J.P., Richards, S.H., Morton, W.H. Howell, S., Williams, E.D., Hourihan, M. & Hall, R. (1985) Management of selected patients with hyperprolactinaemia by partial hypophysectomy. British Medical Journal, 291, 1547-1550.
21. Serri, O., Rasio, E., Beauregard, H., Hardy, J. & Somma, M. (1983) Recurrence of hyperprolactinaemia after selective transsphenoidal adenomectomy in women with prolactinoma. New England Journal of Medicine, 309, 280-283.
22. Thomson, J.A., Teasdale, G.M., Gordon, D., McCruden, D.C. & Davis, D.L. (1985) Treatment of presumed prolactinoma by transsphenoidal operation: early and late results. British Medical Journal, 291, 1550-1553.
23. Tucker, H.S.G., Grubb, S.R., Wigand, J.P., Taylon, A., Lankford, H.V., Blackard, W.G. & Becker, D.P. (1981) Galactorrhoea-amenorrhoea syndrome: follow up of forty-five patients after pituitary tumour removal. Annals of Internal Medicine, 94, 302-307.
24. Webster, J., Page, M.D., Bevan, J.S., Richards, S.H., Douglas-Jones, A.G. & Scanlon, M.F. (1992) Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests. Clinical Endocrinology, 36, 35-44.